Back to top

Culper Research announces Tarsus Pharmaceuticals short position

Culper Research said on X: “NEW: We are short Tarsus Pharmaceuticals (TARS) $TARS, maker of XDEMVY, a $2,000 eyedrop for demodex blepharitis. We th...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Tarsus Pharmaceuticals, Inc. (TARS)